Pulmonx (LUNG) Invested Capital (2021 - 2025)

Pulmonx (LUNG) has 5 years of Invested Capital data on file, last reported at $106000.0 in Q4 2025.

• On a quarterly basis, Invested Capital fell 96.66% year-over-year to $106000.0 in Q4 2025; TTM through Dec 2025 was $8.1 million, a 5.59% decrease from a year earlier, with the FY2025 full-year figure at $106000.0, down 96.66% from the prior year.
• Invested Capital for Q4 2025 stood at $106000.0, up from $105000.0 in the prior quarter.
• Over the last five years, Invested Capital for LUNG reached as high as $7.8 million in Q1 2025 and fell as low as $90000.0 in Q4 2022.
• Historically, Invested Capital has averaged $1.7 million across 5 years, with a median of $289000.0 in 2021.
• Across the five-year window, Invested Capital plunged 98.2% in 2023 and jumped 5648.35% in 2024, its largest moves.
• Year by year, Invested Capital stood at $91000.0 in 2021, then decreased by 1.1% to $90000.0 in 2022, then soared by 2294.44% to $2.2 million in 2023, then surged by 47.38% to $3.2 million in 2024, then sank by 96.66% to $106000.0 in 2025.
• Per Business Quant data, the three most recent Invested Capital figures were $106000.0 in Q4 2025, $105000.0 in Q3 2025, and $104000.0 in Q2 2025.